Literature DB >> 24753176

Patterns of antibacterial use and impact of age, race/ethnicity, and geographic region on antibacterial use in an outpatient medicaid cohort.

Alice M Gahbauer1, Marco L Gonzales, B Joseph Guglielmo.   

Abstract

STUDY
OBJECTIVES: To describe patterns of outpatient antibacterial use among California Medicaid (Medi-Cal) fee-for-service system beneficiaries, and to investigate the influence of demographic factors-age, race/ethnicity, state county, and population density-on those patterns.
DESIGN: Retrospective analysis of administrative claims data. DATA SOURCE: Medi-Cal fee-for-service system claims database. PATIENTS: All outpatient Medi-Cal fee-for-service system beneficiaries enrolled between 2006 and 2011 who had at least one systemic antibacterial claim.
MEASUREMENTS AND MAIN RESULTS: Rates of antibacterial prescribing and the proportion of broad-spectrum antibacterial use were measured over the study period and among age, racial/ethnic, and geographic (county) groups. Of the 10,018,066 systemic antibacterial claims selected for analysis, antibacterial prescribing rates decreased from 542 claims/1000 beneficiaries in 2006 to 461 claims/1000 beneficiaries in 2011 (r = -0.971, p=0.0012; τ-b = -1.00, p=0.009). Among age groups, children had the highest rate of use (605 claims/1000 beneficiaries, χ(2) (2) = 320,000, p<0.001); among racial/ethnic groups, Alaskan Natives and Native Americans had the highest rate of use (1086/1000 beneficiaries, χ(2) (5) = 197,000, p<0.001). Broad-spectrum antibacterial prescribing increased from 28.1% (95% confidence interval [CI] 28.1-28.2%) to 32.7% (95% CI 32.6-32.8%) over the study period. Senior age groups and whites received the highest proportions of broad-spectrum agents (53.4% [95% CI 52.5-54.3%] and 36.6% [95% CI 36.6-36.7%], respectively). Population density was inversely related to both overall antibacterial use (ρ = -0.432, p=0.0018) and broad-spectrum antibacterial prescribing (ρ = -0.359, p<0.001). The rate of prescribing decreased over the study period for all antibacterial classes with the exception of macrolides and sulfonamides. Amoxicillin was the most frequently prescribed agent.
CONCLUSION: Overall and broad-spectrum antibacterial use in the Medi-Cal fee-for-service program are less than that observed nationally. Significant variations in prescribing exist between age and racial/ethnic groups, and heavily populated areas are associated with both less antibacterial use and less broad-spectrum antibacterial prescribing. Studies are needed to determine the reasons for the observed differences in antibacterial use among demographic groups.
© 2014 Pharmacotherapy Publications, Inc.

Entities:  

Keywords:  Medicaid; antibiotic management; community practice; epidemiology; infectious disease

Mesh:

Substances:

Year:  2014        PMID: 24753176      PMCID: PMC4082730          DOI: 10.1002/phar.1425

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  25 in total

1.  Appropriate antibiotic use: variation in knowledge and awareness by Hispanic ethnicity and language.

Authors:  Kitty K Corbett; Ralph Gonzales; Bonnie A Leeman-Castillo; Estevan Flores; Judy Maselli; Karen Kafadar
Journal:  Prev Med       Date:  2005-02       Impact factor: 4.018

Review 2.  Knowledge, attitudes, and practices regarding antibiotic use among Latinos in the United States: review and recommendations.

Authors:  Amarilis Céspedes; Elaine Larson
Journal:  Am J Infect Control       Date:  2006-10       Impact factor: 2.918

3.  Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries.

Authors:  Herman Goossens; Matus Ferech; Samuel Coenen; Peter Stephens
Journal:  Clin Infect Dis       Date:  2007-03-02       Impact factor: 9.079

4.  Antibacterial use and Streptococcus pneumoniae penicillin resistance: A temporal relationship model.

Authors:  Robertino M Mera; Linda A Miller; Anthony White
Journal:  Microb Drug Resist       Date:  2006       Impact factor: 3.431

5.  Outpatient antibiotic use in Europe and association with resistance: a cross-national database study.

Authors:  Herman Goossens; Matus Ferech; Robert Vander Stichele; Monique Elseviers
Journal:  Lancet       Date:  2005 Feb 12-18       Impact factor: 79.321

6.  Quality of US outpatient care: temporal changes and racial/ethnic disparities.

Authors:  Jun Ma; Randall S Stafford
Journal:  Arch Intern Med       Date:  2005-06-27

7.  Ambulatory antibiotic use and prescription drug coverage in older adults.

Authors:  Yuting Zhang; Bruce Y Lee; Julie M Donohue
Journal:  Arch Intern Med       Date:  2010-08-09

8.  Variation in outpatient antibiotic prescribing in the United States.

Authors:  Michael A Steinman; Katherine Y Yang; Sepheen C Byron; Judith H Maselli; Ralph Gonzales
Journal:  Am J Manag Care       Date:  2009-12       Impact factor: 2.229

9.  Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings.

Authors:  Carlos G Grijalva; J Pekka Nuorti; Marie R Griffin
Journal:  JAMA       Date:  2009-08-19       Impact factor: 56.272

10.  Community prescribing and resistant Streptococcus pneumoniae.

Authors:  Galia Barkai; David Greenberg; Noga Givon-Lavi; Eli Dreifuss; Daniel Vardy; Ron Dagan
Journal:  Emerg Infect Dis       Date:  2005-06       Impact factor: 6.883

View more
  5 in total

Review 1.  Antibiotic resistance: a primer and call to action.

Authors:  Rachel A Smith; Nkuchia M M'ikanatha; Andrew F Read
Journal:  Health Commun       Date:  2014-08-14

2.  Changes in Outpatient Use of Antibiotics by Adults in the United States, 2006-2015.

Authors:  Mallika L Mundkur; Jessica Franklin; Krista F Huybrechts; Michael A Fischer; Aaron S Kesselheim; Jeffrey A Linder; Joan Landon; Elisabetta Patorno
Journal:  Drug Saf       Date:  2018-12       Impact factor: 5.606

3.  Individuals hospitalized with acute mania have increased exposure to antimicrobial medications.

Authors:  Robert Yolken; Maria Adamos; Emily Katsafanas; Sunil Khushalani; Andrea Origoni; Christina Savage; Lucy Schweinfurth; Cassie Stallings; Kevin Sweeney; Faith Dickerson
Journal:  Bipolar Disord       Date:  2016-07-17       Impact factor: 6.744

4.  Evaluation of Clarithromycin Resistance Among Iranian Helicobacter pylori Isolates by E-Test and Real-Time Polymerase Chain Reaction Methods.

Authors:  Mojdeh Hakemi Vala; Shirin Eyvazi; Hossein Goudarzi; Hamid Reza Sarie; Mehrdad Gholami
Journal:  Jundishapur J Microbiol       Date:  2016-03-19       Impact factor: 0.747

5.  Clostridium difficile infection health disparities by race among hospitalized adults in the United States, 2001 to 2010.

Authors:  Jacqueline R Argamany; Andrew Delgado; Kelly R Reveles
Journal:  BMC Infect Dis       Date:  2016-08-27       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.